BROOMFIELD, Colo., Sept. 29, 2011 (GLOBE NEWSWIRE) -- Lanx, Inc., a privately held medical device company focused on developing and commercializing innovative devices for spinal surgery, today announced the full commercial launch of the Aspen™ Flared 5-1 MIS Fusion System, the spinous process fixation device specifically designed to promote fusion at L5-S1. The Company will be showcasing Aspen Flared 5-1 along with the entire Aspen MIS Fusion System at the Congress of Neurological Surgeons (CNS) 2011 Annual Meeting, October 1-6 in Washington, DC.
Dan Gladney, Chief Executive Officer, Lanx, commented, "Our market-leading Aspen Family offers surgeons and patients a less invasive spinal fusion option, biomechanically comparable in strength and stability to pedicle screws. The Aspen Flared 5-1 device is a minimally invasive fusion solution optimized for L5-S1 and further extends Lanx's offering of spinous process fixation devices."
The Aspen Flared 5-1 device builds on the clinical success of the Aspen Family to provide rigid posterior fixation at the L5-S1 level, which is involved in over 40 percent of lumbar fusion cases. The device features a unique angle on each ventral plate for improved anatomic fit at L5-S1 by conforming to the sacral anatomy. The flared angle also allows the implant to securely fixate at the laminar junction of any level for anterior placement and optimal bony engagement.
"The L5-S1 area is especially susceptible to degeneration and can be challenging to adequately fixate due to unique anatomy. The Aspen Flared 5-1 design offers the benefits of minimally invasive Aspen spinous process fixation to patients with instability at this level, and the ability for ventral implant placement ensures optimal fixation to the thicker, stronger bone at the base of the spinous process," said Randall Porter, MD, Barrow Neurological Institute, Phoenix, AZ.
The Aspen MIS Fusion System is a family of minimally invasive spinous process fixation devices designed to promote fusion. The Aspen Family includes the standard Aspen, Aspen Flared 5-1, Aspen Medium and LPlate Low Profile implants, all designed to accommodate different patient anatomies with a variety of shapes and sizes. Aspen devices are intended for single level use in the non-cervical spine (T1-S1) for the treatment of degenerative disc disease, spondylolisthesis, spinal trauma or spinal tumor. The Aspen Family is currently being used in a wide range of surgical applications including posterior fusion and interbody fusion (Lateral, ALIF and TLIF).
Lanx markets a full line of spine stabilization technologies that will be on display at the Lanx CNS booth #1309. For more information about the Aspen Family or Lanx, please visit www.lanx.com.
About Lanx, Inc.
Lanx is one of the largest privately held global spine companies. The Company was founded in 2003 to improve the quality of spine care and provide surgeons with innovative products. Lanx develops and markets a full line of fusion technologies with a focus on minimally invasive and biologics products. The Company is headquartered in Broomfield, CO. More information on Lanx and its spinal surgery products can be found at www.lanx.com.